Publication | Closed Access

Bevacizumab with FOLFOXIRI (irinotecan, oxaliplatin, fluorouracil, and folinate) as first-line treatment for metastatic colorectal cancer: a phase 2 trial

OncologyGastrointestinal OncologyMedicineColorectal CancerPathologyMetastatic Colorectal CancerFirst-line TreatmentPharmacotherapyCancer TreatmentPhase 2PharmacologyRadiation Oncology